General Information of Drug Off-Target (DOT) (ID: OTMHM1DH)

DOT Name Bis(5'-nucleosyl)-tetraphosphatase (NUDT2)
Synonyms EC 3.6.1.17; Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase; Ap4A hydrolase; Ap4Aase; Diadenosine tetraphosphatase; Nucleoside diphosphate-linked moiety X motif 2; Nudix motif 2
Gene Name NUDT2
Related Disease
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Dilated cardiomyopathy 1A ( )
Ductal breast carcinoma in situ ( )
Intellectual developmental disorder with or without peripheral neuropathy ( )
Invasive ductal breast carcinoma ( )
Malaria ( )
Intellectual disability ( )
Neurodevelopmental disorder ( )
Advanced cancer ( )
UniProt ID
AP4A_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1XSA; 1XSB; 1XSC; 3U53; 4ICK; 4IJX
EC Number
3.6.1.17
Pfam ID
PF00293
Sequence
MALRACGLIIFRRCLIPKVDNNAIEFLLLQASDGIHHWTPPKGHVEPGEDDLETALRETQ
EEAGIEAGQLTIIEGFKRELNYVARNKPKTVIYWLAEVKDYDVEIRLSHEHQAYRWLGLE
EACQLAQFKEMKAALQEGHQFLCSIEA
Function Catalyzes the asymmetric hydrolysis of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) to yield AMP and ATP. Exhibits decapping activity towards FAD-capped RNAs and dpCoA-capped RNAs in vitro.
KEGG Pathway
Purine metabolism (hsa00230 )
Pyrimidine metabolism (hsa00240 )
Metabolic pathways (hsa01100 )
Reactome Pathway
Detoxification of Reactive Oxygen Species (R-HSA-3299685 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Strong Biomarker [1]
Breast carcinoma DIS2UE88 Strong Biomarker [1]
Breast neoplasm DISNGJLM Strong Biomarker [1]
Dilated cardiomyopathy 1A DIS0RK9Z Strong Biomarker [1]
Ductal breast carcinoma in situ DISLCJY7 Strong Biomarker [1]
Intellectual developmental disorder with or without peripheral neuropathy DISRA4KS Strong Autosomal recessive [2]
Invasive ductal breast carcinoma DIS43J58 Strong Biomarker [1]
Malaria DISQ9Y50 Strong Biomarker [3]
Intellectual disability DISMBNXP moderate Biomarker [4]
Neurodevelopmental disorder DIS372XH moderate Genetic Variation [4]
Advanced cancer DISAT1Z9 Limited Biomarker [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Biotransformations of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
DIADENOSINE TETRAPHOSPHATE DMTJOEL Phase 2 Bis(5'-nucleosyl)-tetraphosphatase (NUDT2) increases the hydrolysis of DIADENOSINE TETRAPHOSPHATE. [1]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Bis(5'-nucleosyl)-tetraphosphatase (NUDT2). [6]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the methylation of Bis(5'-nucleosyl)-tetraphosphatase (NUDT2). [11]
------------------------------------------------------------------------------------
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Bis(5'-nucleosyl)-tetraphosphatase (NUDT2). [7]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Bis(5'-nucleosyl)-tetraphosphatase (NUDT2). [8]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Bis(5'-nucleosyl)-tetraphosphatase (NUDT2). [1]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Bis(5'-nucleosyl)-tetraphosphatase (NUDT2). [10]
------------------------------------------------------------------------------------

References

1 Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Int J Cancer. 2011 Apr 15;128(8):1770-82. doi: 10.1002/ijc.25505.
2 Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. Mol Psychiatry. 2017 Apr;22(4):615-624. doi: 10.1038/mp.2016.113. Epub 2016 Jul 19.
3 Functional genetic evaluation of DNA house-cleaning enzymes in the malaria parasite: dUTPase and Ap4AH are essential in Plasmodium berghei but ITPase and NDH are dispensable.Expert Opin Ther Targets. 2019 Mar;23(3):251-261. doi: 10.1080/14728222.2019.1575810. Epub 2019 Feb 13.
4 A founder nonsense variant in NUDT2 causes a recessive neurodevelopmental disorder in Saudi Arab children.Clin Genet. 2018 Oct;94(3-4):393-395. doi: 10.1111/cge.13386. Epub 2018 Jul 30.
5 NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes.PLoS One. 2016 May 4;11(5):e0154674. doi: 10.1371/journal.pone.0154674. eCollection 2016.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
8 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
9 Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Int J Cancer. 2011 Apr 15;128(8):1770-82. doi: 10.1002/ijc.25505.
10 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
11 Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol. 2012 Jul;41(1):369-77.
12 Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Int J Cancer. 2011 Apr 15;128(8):1770-82. doi: 10.1002/ijc.25505.